Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Age adjustment in ecological studies: using a study on arsenic ingestion and bladder cancer as an example.

Guo HR.

BMC Public Health. 2011 Oct 20;11:820. doi: 10.1186/1471-2458-11-820.

2.

Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan.

Lamm SH, Byrd DM, Kruse MB, Feinleib M, Lai SH.

Biomed Environ Sci. 2003 Dec;16(4):355-68.

PMID:
15011967
3.

Estimating water supply arsenic levels in the New England Bladder Cancer Study.

Nuckols JR, Freeman LE, Lubin JH, Airola MS, Baris D, Ayotte JD, Taylor A, Paulu C, Karagas MR, Colt J, Ward MH, Huang AT, Bress W, Cherala S, Silverman DT, Cantor KP.

Environ Health Perspect. 2011 Sep;119(9):1279-85. doi: 10.1289/ehp.1002345. Epub 2011 Mar 21. Erratum in: Environ Health Perspect. 2011 Dec;119(12):A509.

4.

Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.

Chen CH, Chiou HY, Hsueh YM, Chen CJ, Yu HJ, Pu YS.

J Urol. 2009 Feb;181(2):547-52; discussion 553. doi: 10.1016/j.juro.2008.10.003. Epub 2008 Dec 13.

PMID:
19084863
5.

Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.

Mendez WM Jr, Eftim S, Cohen J, Warren I, Cowden J, Lee JS, Sams R.

J Expo Sci Environ Epidemiol. 2017 May;27(3):235-243. doi: 10.1038/jes.2016.58. Epub 2016 Nov 30.

PMID:
27901016
6.
7.

Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.

Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ.

Am J Epidemiol. 2001 Mar 1;153(5):411-8.

PMID:
11226969
8.

Arsenic level in drinking water and mortality of lung cancer (Taiwan).

Guo HR.

Cancer Causes Control. 2004 Mar;15(2):171-7.

PMID:
15017129
9.

Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.

Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D.

Am J Epidemiol. 2004 Nov 1;160(9):853-9.

PMID:
15496537
10.

Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.

Christoforidou EP, Riza E, Kales SN, Hadjistavrou K, Stoltidi M, Kastania AN, Linos A.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2013;48(14):1764-75. doi: 10.1080/10934529.2013.823329. Review.

PMID:
24007431
11.

Incorporating individual-level distributions of exposure error in epidemiologic analyses: an example using arsenic in drinking water and bladder cancer.

Meliker JR, Goovaerts P, Jacquez GM, Nriagu JO.

Ann Epidemiol. 2010 Oct;20(10):750-8. doi: 10.1016/j.annepidem.2010.06.012.

12.

Increased lung and bladder cancer incidence in adults after in utero and early-life arsenic exposure.

Steinmaus C, Ferreccio C, Acevedo J, Yuan Y, Liaw J, Durán V, Cuevas S, García J, Meza R, Valdés R, Valdés G, Benítez H, VanderLinde V, Villagra V, Cantor KP, Moore LE, Perez SG, Steinmaus S, Smith AH.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1529-38. doi: 10.1158/1055-9965.EPI-14-0059. Epub 2014 May 23.

13.

Arsenic cancer risk confounder in southwest Taiwan data set.

Lamm SH, Engel A, Penn CA, Chen R, Feinleib M.

Environ Health Perspect. 2006 Jul;114(7):1077-82.

14.

Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.

Meliker JR, Slotnick MJ, AvRuskin GA, Schottenfeld D, Jacquez GM, Wilson ML, Goovaerts P, Franzblau A, Nriagu JO.

Cancer Causes Control. 2010 May;21(5):745-57. doi: 10.1007/s10552-010-9503-z. Epub 2010 Jan 19.

15.

Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.

Lamm SH, Robbins SA, Zhou C, Lu J, Chen R, Feinleib M.

Regul Toxicol Pharmacol. 2013 Feb;65(1):147-56. doi: 10.1016/j.yrtph.2012.10.012. Epub 2012 Nov 5.

17.

Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.

Huang YK, Huang YL, Hsueh YM, Yang MH, Wu MM, Chen SY, Hsu LI, Chen CJ.

Cancer Causes Control. 2008 Oct;19(8):829-39. doi: 10.1007/s10552-008-9146-5. Epub 2008 Mar 20.

PMID:
18351295
18.

Bladder cancer mortality associated with arsenic in drinking water in Argentina.

Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, Smith AH.

Epidemiology. 1996 Mar;7(2):117-24. Erratum in: Epidemiology 1997 May;8(3):334.

PMID:
8834549
19.

Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland.

Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J.

Environ Health Perspect. 1999 Sep;107(9):705-10.

20.

Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.

Lynch HN, Zu K, Kennedy EM, Lam T, Liu X, Pizzurro DM, Loftus CT, Rhomberg LR.

Environ Int. 2017 Sep;106:178-206. doi: 10.1016/j.envint.2017.04.008. Epub 2017 Jun 16. Erratum in: Environ Int. 2017 Dec;109 :195-196.

PMID:
28625818

Supplemental Content

Support Center